Pulmonary pseudoneoplasms

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 3, 2010, Pages 417-426

  Yi, Eunhee ^a   Aubry, Marie Christine ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LUNG DISEASE; LUNG TUMOR; MALE; PLASMA CELL GRANULOMA;

DIAGNOSIS, DIFFERENTIAL; FEMALE; GRANULOMA, PLASMA CELL; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MALE;

EID: 77749318577     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Bahadori M, Liebow AA. Plasma cell granulomas of the lung. Cancer. 1973; 31:191-208.
2. Snyder CS, Dell'Aquila M, Haghighi P, Baergen RN, Suh YK, Yi ES. Clonal changes in inflammatory pseudotumor of the lung: a case report. Cancer. 1995; 76:1545-1549.
3. Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor): a clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995;19:859-872.
4. Zen Y, Kitagawa S, Minato H, et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol. 2005;36: 710-717.
5. Gómez-Román JJ, Sánchez-Velasco P, Ocejo-Vinyals G, Hernández-Nieto E, Leyva-Cobián F, Val-Bernal JF. Human herpesvirus-8 genes are expressed in pulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor).Am J Surg Pathol. 2001;25:624-629.
6. Kutok JL, Pinkus GS, Dorfman DM, Fletcher CD. Inflammatory pseudotumor of lymph node and spleen: an entity biologically distinct from inflammatory myofibroblastic tumor. Hum Pathol. 2001;32:1382-1387.
7. Tavora F, Shilo K, Ozbudak IH, et al. Absence of human herpesvirus-8 in pulmonary inflammatory myofibroblastic tumor: immunohistochemical and molecular analysis of 20 cases. Mod Pathol. 2007;20:995-999.
8. Yamamoto H, Kohashi K, Oda Y, et al. Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene. Pathol Int. 2006;56:584-590.
9. Swain RS, Tihan T, Horvai AE, et al. Inflammatory myofibroblastic tumor of the central nervous system and its relationship to inflammatory pseudotumor. Hum Pathol. 2008;39:410-419.
10. Coyne JD, Wilson G, Sandhu D, Young RH. Inflammatory pseudotumour of the urinary bladder. Histopathology. 1991;18:261-264.
11. Sukov WR, Cheville JC, Carlson AW, et al. Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder. Mod Pathol. 2007;20:592-603.
12. Tsuzuki T, Magi-Galluzzi C, Epstein JI. ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder. Am J Surg Pathol. 2004;28:1609-1614.
13. Meis JM, Enzinger FM. Inflammatory fibrosarcoma of the mesentery and retroperitoneum: a tumor closely simulating inflammatory pseudotumor. Am J Surg Pathol. 1991;15:1146-1156.
14. Coffin CM, Dehner LP, Meis-Kindblom JM. Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations. Semin Diagn Pathol. 1998;15:102-110.
15. Griffin CA, Hawkins AL, Dvorak C, Henkle C, Ellingham T, Perlman EJ. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. Cancer Res. 1999;59:2776-2780.
16. Lawrence B, Perez-Atayde A, Hibbard MK, et al. TPM3-ALK and TPM4- ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol. 2000;157: 377-384.
17. Bridge JA, Kanamori M, Ma Z, et al. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol. 2001;159:411-415.
18. Yousem SA, Shaw H, Cieply K. Involvement of 2p23 in pulmonary inflammatory pseudotumors. Hum Pathol. 2001;32:428-433.
19. Chan JK, Cheuk W, Shimizu M. Anaplastic lymphoma kinase expression in inflammatory pseudotumors. Am J Surg Pathol. 2001;25:761-768. (Pubitemid 32496865)
20. Cook JR, Dehner LP, Collins MH, et al. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol. 2001;25:1364-1371.
21. Cessna MH, Zhou H, Sanger WG, et al. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol. 2002;15:931-938.
22. Li XQ, Hisaoka M, Shi DR, Zhu XZ, Hashimoto H. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases. Hum Pathol. 2004;35:711-721.
23. Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31:509-520.
24. Matsubara O, Tan-Liu NS, Kenney RM, Mark EJ. Inflammatory pseudotumors of the lung: progression from organizing pneumonia to fibrous histiocytoma or to plasma cell granuloma in 32 cases. Hum Pathol. 1988;19:807-814.
25. Gal AA, Koss MN, McCarthy WF, Hochholzer L. Prognostic factors in pulmonary fibrohistiocytic lesions. Cancer. 1994;73:1817-1824.
26. Warter A, Satge D, Roeslin N. Angioinvasive plasma cell granulomas of the lung. Cancer. 1987;59:435-443.
27. Ledet SC, Brown RW, Cagle PT. p53 immunostaining in the differentiation of inflammatory pseudotumor from sarcoma involving the lung. Mod Pathol. 1995;8:282-286.
28. Applebaum H, Kieran MW, Cripe TP, et al. The rationale for nonsteroidal anti-inflammatory drug therapy for inflammatory myofibroblastic tumors: a Children's Oncology Group study [discusson in J Pediatr Surg. 2005;40:1003]. J Pediatr Surg. 2005;40:999-1003.
29. Myers JL, Colby TV. Pathologic manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse panbronchiolitis. Clin Chest Med. 1993;14:611-622.
30. Colby TV. Bronchiolitis: pathologic considerations. Am J Clin Pathol. 1998; 109:101-109.
31. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165:277-304.
32. Maldonado F, Daniels CE, Hoffman EA, Yi ES, Ryu JH. Focal organizing pneumonia on surgical lung biopsy: causes, clinicoradiologic features, and outcomes. Chest. 2007;132:1579-1583.
33. Kradin RL, Mark EJ. Benign lymphoid disorders of the lung, with a theory regarding their development. Hum Pathol. 1983;14:857-867.
34. Saltzstein SL. Pulmonary malignant lymphomas and pseudolymphomas: classification, therapy, and prognosis. Cancer. 1963;16:928-955.
35. Abbondanzo SL, Rush W, Bijwaard KE, Koss MN. Nodular lymphoid hyperplasia of the lung: a clinicopathologic study of 14 cases. Am J Surg Pathol. 2000;24:587-597.
36. Butler C II, Kleinerman J. The pulmonary apical cap. Am J Pathol. 1970; 60:205-216.
37. McLoud TC, Isler RJ, Novelline RA, Putman CE, Simeone J, Stark P. The apical cap. AJR Am J Roentgenol. 1981;137:299-306.
38. Im JG, Webb WR, Han MC, Park JH. Apical opacity associated with pulmonary tuberculosis: high-resolution CT findings. Radiology. 1991;178:727-731.
39. Yousem SA. Pulmonary apical cap: a distinctive but poorly recognized lesion in pulmonary surgical pathology [comment in Am J Surg Pathol. 2001; 25(10):1344]. Am J Surg Pathol. 2001;25:679-683.
40. Solovay J, Solovay HU. Apical pulmonary tumors-relation to apical scarring. Dis Chest. 1965;48:20-28.
41. Colby TV. Malignancies in the lung and pleura mimicking benign processes. Semin Diagn Pathol. 1995;12:30-44.
42. Dernevik L, Gatzinsky P, Hultman E, Selin K,William-Olsson G, Zettergren L. Shrinking pleuritis with atelectasis. Thorax. 1982;37:252-258.
43. Stark P. Round atelectasis: another pulmonary pseudotumor. Am Rev Respir Dis. 1982;125:248-250.
44. Schneider HJ, Felson B, Gonzalez LL. Rounded atelectasis. AJR Am J Roentgenol. 1980;134:225-232.
45. Mintzer RA, Cugell DW. The association of asbestos-induced pleural disease and rounded atelectasis. Chest. 1982;81:457-460.
46. Menzies R, Fraser R. Round atelectasis: pathologic and pathogenetic features. Am J Surg Pathol. 1987;11:674-681.
47. Hillerdal G. Rounded atelectasis: clinical experience with 74 patients. Chest. 1989;95:836-841.
48. Dernevik L, Gatzinsky P. Pathogenesis of shrinking pleuritis with atelectasis - " rounded atelectasis". Eur J Respir Dis. 1987;71:244-249.
49. O'Donovan PB, Schenk M, Lim K, Obuchowski N, Stoller JK. Evaluation of the reliability of computed tomographic criteria used in the diagnosis of round atelectasis. J Thorac Imaging. 1997;12:54-58.
50. Batra P, Brown K, Hayashi K, Mori M. Rounded atelectasis. J Thorac Imaging. 1996;11:187-197.
51. Cohen AM, Crass JR, Chung-Park M, Tomashefski JF Jr. Rounded atelectasis and fibrotic pleural disease: the pathologic continuum. J Thorac Imaging. 1993; 8:309-312.
52. Chung-Park M, Tomashefski JF Jr, Cohen AM, el-Gazzar M, Cotes EE. Shrinking pleuritis with lobar atelectasis, a morphologic variant of "round atelectasis". Hum Pathol. 1989;20:382-387.
53. Mathisen DJ, Grillo HC. Clinical manifestation of mediastinal fibrosis and histoplasmosis [discussion in Ann Thorac Surg. 1992;54:1057-1058]. AnnThorac Surg. 1992;54:1053-1057.
54. Mole TM, Glover J, Sheppard MN. Sclerosing mediastinitis: a report on 18 cases. Thorax. 1995;50:280-283.
55. Devaraj A, Griffin N, Nicholson AG, Padley SP. Computed tomography findings in fibrosing mediastinitis. Clin Radiol. 2007;62:781-786.
56. Rossi SE, McAdams HP, Rosado-de-Christenson ML, Franks TJ, Galvin JR. Fibrosing mediastinitis. Radiographics. 2001;21:737-757.
57. Dunn EJ, Ulicny KS Jr, Wright CB, Gottesman L. Surgical implications of sclerosing mediastinitis: a report of six cases and review of the literature. Chest. 1990;97:338-346.
58. Dozois RR, Bernatz PE,Woolner LB, Andersen HA. Sclerosing mediastinitis involving major bronchi. Mayo Clin Proc. 1968;43:557-569.
59. Flieder DB, Suster S, Moran CA. Idiopathic fibroinflammatory (fibrosing/ sclerosing) lesions of the mediastinum: a study of 30 cases with emphasis on morphologic heterogeneity. Mod Pathol. 1999;12:257-264.
60. Katzenstein AL, Mazur MT. Pulmonary infarct: an unusual manifestation of fibrosing mediastinitis. Chest. 1980;77:521-524.
61. Dye TE, Saab SB, Almond CH, Watson L. Sclerosing mediastinitis with occlusion of pulmonary veins: manifestations and management. J Thorac Cardiovasc Surg. 1977;74:137-141.
62. Berry DF, Buccigrossi D, Peabody J, Peterson KL, Moser KM. Pulmonary vascular occlusion and fibrosing mediastinitis. Chest. 1986;89:296-301.
63. Williamson WA, Tronic BS, Levitan N, Webb-Johnson DC, Shahian DM, Ellis FH Jr. Pulmonary venous infarction. Chest. 1992;102:937-940.
64. Inoue M, Nose N, Nishikawa H, Takahashi M, Zen Y, Kawaguchi M. Successful treatment of sclerosing mediastinitis with a high serum IgG4 level. Gen Thorac Cardiovasc Surg. 2007;55:431-433.
65. Crotty TB, Colby TV, Gay PC, Pisani RJ. Desmoplastic malignant mesothelioma masquerading as sclerosing mediastinitis: a diagnostic dilemma. Hum Pathol. 1992;23:79-82.
66. Flannery MT, Espino M, Altus P, Messina J,Wallach PM. Hodgkin's disease masquerading as sclerosing mediastinitis. South Med J. 1994;87:921-923.
67. Engleman P, Liebow AA, Gmelich J, Friedman PJ. Pulmonary hyalinizing granuloma. Am Rev Respir Dis. 1977;115:997-1008.
68. Yousem SA, Hochholzer L. Pulmonary hyalinizing granuloma. Am J Clin Pathol. 1987;87:1-6.